Borderline ovarian tumour
Exam relevance: in 5 of more than 150 board exam reports · rank 101
- Specialty
- Gynaecology · Ovary & adnexa
- Images
- Histology & cytology 1 · Ultrasound 1
- Exam relevance
- 5 of more than 150 reports · rank 101
- In the app
- 1 flashcard · GynFuchs
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (2)
Histology & cytology
UltrasoundDefinition
- Definition: A borderline tumour is an epithelial tumour with cellular atypia and proliferation, but without destructive stromal invasion.
- Patient population: It often affects significantly younger women than invasive carcinoma, often with a desire to have children.
- Ultrasound: On ultrasound, it is often noted for papillary projections in an otherwise unilocular cyst.
- Borderline ovarian tumours are epithelial tumours whose behaviour lies between benign tumours and invasive carcinomas.
- They show no destructive stromal invasion, which distinguishes them from other ovarian neoplasms.
Classification
Staging
- Mucinous subtype: For a mucinous borderline tumour, infracolic omentectomy and assessment of the appendix is added.
- The commonest subtypes are serous (about 50%) and mucinous (about 45%); endometrioid, clear cell, seromucinous and Brenner borderline tumours are rarer.
- Despite the absence of stromal invasion, microinvasion, lymph node involvement and non-invasive or invasive peritoneal implants may occur.
Occurrence & epidemiology
Epidemiology
- They occur in 1.8–4.8 per 100,000 women per year and make up 10–20% of epithelial ovarian tumours; women of reproductive age are frequently affected.
Aetiopathogenesis
Pathogenesis
- Molecularly, borderline tumours resemble low-grade serous carcinomas; in some cases a gradual progression from cystadenoma through borderline tumour to low-grade serous carcinoma has been observed.
- The BRAF V600E mutation is found in up to 40% of serous borderline tumours.
Diagnosis
- Before histological confirmation, assessment relies on markers such as CA 125, HE4 and the ROMA algorithm; imaging and tumour markers alone cannot reliably distinguish a borderline tumour from early ovarian carcinoma.
- The diagnosis is histological; frozen section is less accurate for borderline tumours than for benign or malignant tumours, and particularly in bulky tumours microinvasion or intraepithelial carcinoma may be missed.
Treatment principles
- Treatment is surgical, with complete tumour removal, inspection of the entire abdomen and peritoneal sampling.
- Where fertility is desired, a fertility-sparing approach preserving the uterus and healthy ovarian tissue is possible, at the cost of a somewhat higher recurrence risk.
- Adjuvant chemotherapy is generally not indicated; because late recurrences can occur, long-term follow-up is arranged.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
More topics: Ovary & adnexa
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Corpus luteum cyst and haemorrhagic ovarian cyst · Fitz-Hugh-Curtis syndrome · Granulosa cell tumour and sex cord-stromal tumours
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.